Etofylline nicotinate

Etofylline nicotinate is a drug used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is a combination of theophylline and nicotinate. Theophylline is a bronchodilator, and nicotinate is an anti-inflammatory agent. This combination helps reduce airway inflammation and improve bronchodilator activity. It works by relaxing the muscles around the airways, which helps to reduce airway obstruction. The drug is usually taken orally in tablet form, although it may also be available in an inhaler form. Etofylline nicotinate is generally well tolerated, but side effects such as nausea, dizziness, headache, and insomnia may occur.

Etofylline nicotinate is a medication that acts as a vasodilator. Here's a breakdown of its key points:

Function:

  • Relaxes smooth muscle tissue, particularly in blood vessels, causing them to widen (vasodilation). This improves blood flow.

Uses:

  • Limited information exists regarding current uses.
  • Historically, it has been used for conditions potentially benefiting from improved blood flow, but there might be more effective options available now.

Important Notes:

  • Not widely prescribed: Consult a doctor to understand if it's a suitable treatment for your specific condition.
  • Limited information: More research may be needed to fully understand its effectiveness and safety profile.

Safety:

  • Advise a doctor about any other medications you're taking to avoid potential interactions.
  • Information on side effects is limited, so discuss any concerns with a doctor.
Anatomical Therapeutic Chemical Classification
C - Cardiovascular system
C04 Peripheral vasodilators
C04A - Peripheral vasodilators
C04AD Purine derivatives
External Links